RedHill Biopharma (RDHL) Change in Receivables (2017 - 2022)
RedHill Biopharma (RDHL) posted quarterly Change in Receivables of $1.5 million for Q4 2022, up 190.55% year-over-year from $511101.8 in Q4 2021, and up 165.94% quarter-over-quarter from -$2.3 million in Q3 2022.
RedHill Biopharma (RDHL) Change in Receivables (2017 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Change in Receivables for 6 consecutive years, with $1.5 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Change in Receivables rose 190.55% year-over-year to $1.5 million; the TTM figure through Dec 2022 stood at -$2.8 million (up 5.83% YoY), while the FY2025 annual figure was $2.3 million, up 4244.23% from the prior year.
- Change in Receivables grew to $1.5 million in Q4 2022 per RDHL's latest filing, from -$2.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $6.1 million in Q3 2020 and bottomed at -$16.9 million in Q2 2020.
- Historically, Change in Receivables has averaged -$1.6 million across 5 years, with a median of -$202500.0 in 2018.
- On a YoY basis, Change in Receivables climbed as much as 5487.27% in 2020 and fell as far as 4371.35% in 2020.
- RedHill Biopharma's Change in Receivables stood at $962000.0 in 2018, then slumped by 137.73% to -$363000.0 in 2019, then slumped by 4371.35% to -$16.2 million in 2020, then surged by 89.9% to -$1.6 million in 2021, then surged by 190.55% to $1.5 million in 2022.
- Business Quant data shows RDHL's Change in Receivables at $1.5 million in Q4 2022, -$2.3 million in Q3 2022, and -$7.8 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.49 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | -2.25 Mn |
| Sep 30, 2022 | -2.25 Mn |
| Jun 30, 2022 | -7.82 Mn |
| Jun 30, 2022 | -7.82 Mn |
| Mar 31, 2022 | 5.74 Mn |
| Mar 31, 2022 | 5.74 Mn |
| Dec 31, 2021 | -1.64 Mn |
| Dec 31, 2021 | -1.64 Mn |
| Sep 30, 2021 | 62,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | -6.79 Mn |
| Jun 30, 2021 | -6.79 Mn |
| Mar 31, 2021 | 5.35 Mn |
| Mar 31, 2021 | 5.35 Mn |
| Dec 31, 2020 | -16.23 Mn |
| Dec 31, 2020 | -16.23 Mn |
| Sep 30, 2020 | 6.15 Mn |
| Sep 30, 2020 | 6.15 Mn |